Get started
RocketTickers

Seelos Therapeutics Announces FDA Acceptance of Investigational

Long
Seelos Therapeutics, Inc. (NASDAQ:SEEL)  
RocketTickers  
NASDAQ:SEEL   Seelos Therapeutics, Inc.
Beyond Technical Analysis
3
0
beyondta
SEEL: Seelos Therapeutics, Inc.
2021-11-08 08:00:00
Seelos Therapeutics Announces FDA Acceptance of Investigational New Drug Application and Grant of Fast Track Designation for SLS-005 (IV Trehalose) for the Treatment of Spinocerebellar Ataxia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.